Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease
Clinical trial NCT05931575 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05931575
- Sponsor
- Technical University of Munich
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-11
- Primary completion
- 2026-09-30
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.